What Happened?

Shares of dental products company Dentsply Sirona (NASDAQ: XRAY) jumped 3.5% in the morning session after the company announced the appointment of a new CEO, released positive preliminary second-quarter results, and reaffirmed its full-year 2025 financial outlook. 

The company named Daniel Scavilla, a current board member and former CEO of Globus Medical, as its new President and CEO, effective August 1, 2025. Scavilla brings decades of experience in the medical technology and pharmaceutical sectors. Alongside the leadership change, Dentsply Sirona provided an encouraging financial update. It expects second-quarter net sales of approximately $935 million and adjusted earnings per share (EPS) between $0.50 and $0.52. This compares favorably to consensus estimates of $931.3 million in revenue and an EPS of $0.497. The company also confirmed its 2025 guidance, signaling confidence in its strategic direction. The positive news was compounded by M&A activity in the dental sector, as competitor ZimVie announced it would be acquired by investment firm ARCHIMED at a significant premium.

After the initial pop the shares cooled down to $15.95, up 1.7% from previous close.

Is now the time to buy Dentsply Sirona? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Dentsply Sirona’s shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 2 months ago when the stock gained 6% on the news that the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains. 

However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels. Still, the agreement  cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueled renewed optimism. The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand.

Dentsply Sirona is down 14.9% since the beginning of the year, and at $15.95 per share, it is trading 41.2% below its 52-week high of $27.14 from July 2024. Investors who bought $1,000 worth of Dentsply Sirona’s shares 5 years ago would now be looking at an investment worth $363.75.

Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.